ArticleJournal of blood medicine2026
Characterization of Inherited Bleeding Disorders in Egyptian Children in a Tertiary Care Center: A 10 Years Experience.
Article in Journal of blood medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inherited bleeding disorders (IBDs) require accurate diagnosis and long-term management. This study characterized the clinical and hematologic profile of Egyptian children with IBDs managed at Cairo University Children's Hospital and Misr University for Science and Technology. Methods: This retrospective longitudinal observational study included 200 pediatric patients with inherited coagulation or platelet disorders followed between 2015 and 2025. Data collected included demographics, family history, bleeding manifestations, complications, treatment exposure, functional scores, imaging findings, and confirmatory laboratory investigations. Results: Hemophilia A (HA) and von Willebrand disease (vWD) were the most common disorders, accounting for 32.0% and 28.5% of cases, respectively. Among rare inherited coagulation defects, fibrinogen disorders and factor VII deficiency were the most frequent. HA showed the highest hospitalization rate, annual bleeding rate, and ISTH bleeding score, while joint disease was most prominent in hemophilia. Intracranial hemorrhage occurred most often in factor VII deficiency. In HA, the Functional Independence Score of Hemophilia (FISH) was the best discriminator of chronic hemophilic arthropathy (AUC 0.715; cutoff ≤ 26), followed by annual bleeding rate (AUC 0.695; cutoff > 6/year). Persistent high-titer inhibitors developed in 17.2% of HA patients. Most vWD cases were type 1 (75.4%), and Glanzmann thrombasthenia was the most common inherited platelet disorder. Conclusion: Egyptian children with IBDs show heterogeneous clinical presentations and outcomes. Severe phenotypes, particularly HA and type 3 vWD, were associated with earlier bleeding onset, greater morbidity, and the need for individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.